Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
about
PI3K/AKT/mTOR Pathway in AngiogenesisEpicardial-myocardial signaling directing coronary vasculogenesisEffects of angiopoietins-1 and -2 on the receptor tyrosine kinase Tie2 are differentially regulated at the endothelial cell surfaceAnti-angiogenic alternatives to VEGF blockadeMechanisms regulating endothelial permeabilityVascular anomalies: from genetics toward models for therapeutic trialsVascular dysfunction as a target for adjuvant therapy in cerebral malariaPredictive markers of efficacy for an angiopoietin-2 targeting therapeutic in xenograft modelsAngiopoietin-Tie signalling in the cardiovascular and lymphatic systemsEndothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control studyAngiopoietin 2 mediates the differentiation and migration of neural progenitor cells in the subventricular zone after stroke.Low Serum Angiopoietin-1, High Serum Angiopoietin-2, and High Ang-2/Ang-1 Protein Ratio are Associated with Early Onset Sepsis in Surinamese Newborns.Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling.Tie1 controls angiopoietin function in vascular remodeling and inflammation.Dysregulation of angiopoietins is associated with placental malaria and low birth weight.Electroacupuncture improves recovery after hemorrhagic brain injury by inducing the expression of angiopoietin-1 and -2 in rats.Structural basis of Tie2 activation and Tie2/Tie1 heterodimerization.Dimerization of Tie2 mediated by its membrane-proximal FNIII domains.Role of angiopoietin-2 in corneal lymphangiogenesis.Tie2 as a novel key factor of microangiopathy in systemic sclerosis.Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapyHearts of hypoxia-inducible factor prolyl 4-hydroxylase-2 hypomorphic mice show protection against acute ischemia-reperfusion injuryEffects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality.Angiopoietin-2 in experimental colitisExpression and prognostic value of circulating angiogenic cytokines in pancreatic cancer.Opposing effects of the angiopoietins on the thrombin-induced permeability of human pulmonary microvascular endothelial cells.Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-dependent microvascular reactivityAngiogenesis and chronic kidney disease.Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model.Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculatureAutocrine role of angiopoietins during megakaryocytic differentiationAngiopoietin-2-driven vascular remodeling in airway inflammationAn open-label study to determine the maximum tolerated dose of the multitargeted tyrosine kinase inhibitor CEP-11981 in patients with advanced cancer.Molecular control of angiopoietin signalling.Gene expression changes associated with the airway wall response to injury.Expression of Ets-1, Ang-2 and maspin in ovarian cancer and their role in tumor angiogenesis.A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathyAngiopoietins modulate endothelial adaptation, glomerular and podocyte hypertrophy after uninephrectomy.The angiopoietin-Tie2 signaling axis in the vascular leakage of systemic inflammationUrinary angiopoietin-2 is associated with albuminuria in patients with type 2 diabetes mellitus.
P2860
Q21129332-C3464FF8-F6E6-4785-80C2-7BB239B20CE9Q24303956-50FFB644-E628-44E6-BDF4-7B1E10978201Q24318368-DE333DE8-FB0C-4556-BB01-FCAA7C684434Q26775947-021C6DDA-B6F3-4DEC-8FC6-6FE95AABBB8DQ26866511-A08581C2-09E6-4D2E-ACD1-BF4F57442DF7Q27025402-F9550309-AD61-49C4-AD2B-85F49EF939B8Q27025436-756D85D8-A4ED-4AB4-812A-4EBD2A8015B1Q27302122-A924C220-ADE9-4EED-A40A-21C5A1097E4AQ28070234-E2C0BBFC-7533-4467-825E-5DC425F0E904Q28743878-1A9C63E5-9B9D-48CB-941F-7DC072920A41Q30490700-6954E499-B1A8-4A7D-8809-CF4CCB674889Q30491754-B4FA2757-E872-415A-8409-56DD0E42232DQ30514534-A4C040DB-3CC7-4221-AC4D-3471186CF5F9Q30805233-B709367C-6753-4A73-9CF6-48C4CDB79C2EQ30979156-F7D6BD3D-5241-4C08-A2CD-C16932375496Q33574237-4B822931-98A4-42A7-9112-F40178D00682Q33620110-FF276DAB-24D8-482C-9FAB-FE9FBA9F650EQ33620166-98B3AB18-6C29-4608-8576-408A83CFC18AQ33689659-EC8D6C76-237E-4ECE-BA6D-5F98A95F08BAQ33730294-C84CA770-ECF4-439D-8AC9-A0E07B996565Q33779567-1CFBCB5E-1A4B-427C-AFE0-526AB8A09A15Q33810031-69E20D45-D527-4FC5-8AC1-C5973B26B021Q33850993-705354F0-2E7D-4177-97DE-2C89F971C24AQ33897226-06FB5994-CB15-48B4-B95A-B8A7F9B9E404Q33951007-2BD47563-8C2C-4A11-81E0-28DAEC5A699CQ33999630-D0D8F461-2F3E-499B-957E-528E6B1041C9Q34026850-0911A695-617A-4ED9-8B66-8D3DC773C82FQ34075013-7C2A94B8-4447-4E14-A868-41870B47DCC4Q34157162-2078D4E9-4418-4530-A143-975060C1A794Q34311551-234072A0-6284-43CE-99AB-1D560D663A13Q34335730-41A79263-2963-4AB8-AFA2-D5737526DD3EQ34358380-135C60A2-C5A6-4B4F-8BDC-4E3C380A2305Q34484368-E44C77F2-D03E-4EA6-90EC-A0263CBABDD6Q34660609-807AE171-0595-4262-B246-CA008731C1E9Q34672278-608CE7F8-9899-4470-A23D-28A02F09D09DQ34764817-E5A03458-60D0-42DC-BB3D-F629A9437C66Q35027679-34FE1269-1CD1-45A4-93F5-D7C44E945CD5Q35075339-E4343780-B7A2-444E-BD34-AD3AC18F7938Q35212821-96375F29-A3FD-40B3-BF81-23E7A54E2EB3Q35250569-FA2A2C81-4802-49EC-8D72-F0C44F33B483
P2860
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@ast
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en-gb
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@nl
type
label
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@ast
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en-gb
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@nl
prefLabel
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@ast
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en-gb
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@nl
P2093
P2860
P921
P3181
P356
P1476
Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium
@en
P2093
Eliyahu V Khankin
Hai Tao Yuan
Samir M Parikh
P2860
P304
P3181
P356
10.1128/MCB.01472-08
P407
P577
2009-04-01T00:00:00Z